Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-11

FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)

View source ↗

Summary

FDA approves a supplemental application for clotrimazole and betamethasone dipropionate (topical antifungal with corticosteroid) from E. Fougera & Co. The appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clotrimazole and betamethasone dipropionate (clotrimazole and betamethasone dipropionate)

Snippet

SUPPL AP for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE (CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE)